INTRODUCTION {#s1}
============

The current popularity of intensity-modulated radiation therapy (IMRT), an irradiation technique developed to restrict the target dose and spare normal tissue, has improved treatment results \[[@RRS093C1]--[@RRS093C3]\]. This new technique generally employs multiple arc or fixed beams from a linear accelerator. Therefore, considerable time is required to setup each dose, including positioning of the gantry and couch \[[@RRS093C4]--[@RRS093C6]\]. Whereas conventional external beam radiotherapy takes about 2--5 min to deliver a dose fraction, IMRT with static delivery typically requires 15--45 min to deliver the same dose. In the 1960s, Elkind and coworkers \[[@RRS093C7]--[@RRS093C9]\] reported that, after radiation, cultured mammalian cell survival increased when there were intervals between the two radiation doses. This phenomenon is known as repair of sublethal damage (SLDR). The purpose of this study is to investigate the radiobiological effects of prolonged radiation exposure on A549 cells, and the effect of different delivery times with the same dose on tumor growth in nude mice implanted with A549 cells.

MATERIALS AND METHODS {#s2}
=====================

Reagents {#s2a}
--------

The A549 lung cancer cell line was purchased from the Shanghai Cell Bank of the Chinese Academy of Medical Science (acquired from the American Type Culture Collection, Shanghai, China). 1640 culture medium was obtained from GIBCO (Shanghai, China). Fetal calf serum (FCS) was purchased from Hyclone (Shanghai, China). Penicillin and streptomycin were provided by Shanghai Sanda Jinyi Tech Info (Shanghai, China). Hematoxylin and 95% ethanol were purchased from Shanghai Chemical Reagent Factory No. 2 (Shanghai, China).

Cell culture, radiation and radiation schedule {#s2b}
----------------------------------------------

The A549 cells were maintained in 1640 medium containing 20% FCS with 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified atmosphere supplemented with 5% CO~2~at 37°C. Exponentially growing cells were used for experiments. Irradiation was carried out at room temperature using a 180 kV X-ray machine \[X.S.S 250(F2); Guiyang Medical Equipment, Guizhou, China\]. Doses of 0, 2, 4, 6 or 8 Gy were given as a single dose at 102.3 cGy/min. A549 cells were given fractionated radiation in doses of 2 Gy, 2 Gy × 2, 2 Gy × 3, or 2 Gy × 4 at one treatment per day to simulate clinical dose fractionation patterns. Each fraction dose was given in two equal subfractions, with an interval between subfractions of 2 min, 20 min or 40 min per fraction. Three parallel samples were treated at each radiation dose with varying schedules.

Clonogenic assays {#s2c}
-----------------

Cells plated in culture flasks were incubated undisturbed for 10 d. Following radiation exposure, cells were fixed with 95% ethanol and stained with hematoxylin. Colony counts (a colony was defined as 50 or more cells) were performed by visual inspection. Colony plating efficiency was calculated as the number of viable cells expressed as a percentage of cells plated. Cell survival at each dose of each irradiation protocol was determined by dividing the plating efficiency of the irradiated cells by that of the untreated control. Dose-survival curves for each experiment were constructed by plotting the mean surviving fractions semi-logarithmically as a function of irradiation dose. The data were analyzed, and survival curves were plotted following the linear quadratic (LQ) model \[[@RRS093C10], [@RRS093C11]\] using GraphPad Prism 5.0 software (GraphPad Software, San Diego, CA, USA). The value of α and β from the best fit survival curves were used to calculate cell survival at 2 Gy (SF~2~). Differences between the survival under different irradiation protocols were studied with a paired t-test.

Xenograft model radiation and radiation schedule {#s2d}
------------------------------------------------

A549 cells subcultured the day before transplantation were inoculated subcutaneously into the right hind legs (100 000 cells per leg) of male 6--8 week old nude mice. The Ethics Committee of Fudan University Shanghai Cancer Center assessed the procedures and protocols of this manuscript carefully, and confirmed that the animal experiments in this paper have complied fully with the requirements of their Ethics Code of Research involving animals for scientific purposes.

Experiments were performed when the tumor reached 0.8 to 1 cm in diameter. Sixty-four nude mice were randomized into eight groups: control; a single fraction at 15 Gy; two subfractions, with a 20 min interval; five subfractions, with a 5 min interval; nine subfractions, with a 2.5 min interval; two subfractions, with a 40 min interval; five subfractions, with a 10 min interval; and nine subfractions, with a 5 min interval (Fig. [1](#RRS093F1){ref-type="fig"}). Unanesthetized tumor-bearing mice were immobilized in a jig with customized modules and irradiated using a 6 MV X-ray machine (GK-06-100; Shanghai Hi-Tech Radiotherapy Equipment Co., Shanghai, China) at 105.7 cGy/min at a depth of 1 cm. All mice were shielded with a specially designed lead apparatus to allow irradiation only to the right hind limb. Mice were kept under these conditions until all irradiation was finished. Fig. 1.Schematic diagram of radiation schedule.

*In vivo*study {#s2e}
--------------

Tumor dimensions were measured with Vernier calipers once every three days. Tumor volumes were calculated using the Steel formula: *a*\**b*^2^/2. (*a*= length, *b*= width of the tumor). The tumor growth time (TGT) was defined as the time required for the initial tumor size to quadruple after the first day of treatment. The tumor growth delay time was defined as the TGT in each treated animal minus the mean TGT in the control group.

Statistical analysis {#s2f}
--------------------

SPSS v. 16.0 software (SPSS Inc., Chicago, IL, USA) was used for statistical analysis of the data. All data are presented as the mean ± standard deviation (SD) from three independent experiments. A *P*value of less than 0.05 was considered significant.

RESULTS {#s3}
=======

The effect of total interfraction interval time on A549 cells *in vitro* {#s3a}
------------------------------------------------------------------------

A standard dose-survival curve of A549 cells, fit to the standard LQ model, is shown in Fig. [2](#RRS093F2){ref-type="fig"}. The radiobiological characteristics of the A549 cell line, described with the parameters of the mathematical models, are listed in Table [1](#RRS093TB1){ref-type="table"}. A549 cells survived irradiation for a total fraction delivery time of 2, 20 or 40 min in a manner proportional to the interfraction interval (Table [2](#RRS093TB2){ref-type="table"}). Statistical analysis confirmed that longer delivery time is the main reason for higher SF~2~value (Table [3](#RRS093TB3){ref-type="table"}). The dose-survival curve of irradiated A549 cells was fitted to an LQ model (Fig. [2](#RRS093F2){ref-type="fig"}). Effects of fractionated irradiation on A549 cell survival are shown in Fig. [3](#RRS093F3){ref-type="fig"}. Fig. 2.The A549 cell dose-survival curve fitted by the linear-quadratic model. Table 1.A549 cell parameters fit to the LQ modelCell lineSF~2READ~SF~2EST~α (Gy^−1^)β (Gy^−2^)α/β (Gy)A5490.490.500.300.0212.4[^1] Table 2.Surviving fraction of A549 cell irradiated with a total fraction delivery time of 2, 20 or 40 minDOSE (Gy)SF ± SD (2 min)SF ± SD (20 min)SF ± SD (40 min)011120.49 ± 0.270.53 ± 0.040.57 ± 0.0240.20 ± 0.010.21 ± 0.020.24 ± 0.0160.05 ± 0.000.07 ± 0.010.07 ± 0.0080.02 ± 0.000.03 ± 0.000.04 ± 0.00 Table 3.Results of t-tests for cell survival after exposure to 8 Gy using different fraction delivery time protocolsFraction delivery time time protocolsTPIrradiate for 2 min vs 20 min2.070.05Irradiate for 2 min vs 40 min2.150.05Irradiate for 20 min vs 40 min1.800.07

The effect of total interfraction interval time on the growth of tumor tissues {#s3b}
------------------------------------------------------------------------------

The results of the growth delay experiment are shown in Fig. [4](#RRS093F4){ref-type="fig"}, with TGT listed in Table [4](#RRS093TB4){ref-type="table"}. The effects of 15 Gy given in 40 min were much lower than that of a single 15 Gy dose, but there were no substantial differences between the 20 min group and the single 15 Gy dose group. A 15 Gy dose given as 2, 5 or 9 subfractions in 20 min or in 40 min did not make a difference (*P*\> 0.05; Table [5](#RRS093TB5){ref-type="table"}). However, 15 Gy given in 40 min had significantly less effect than 20 min \[20′ (7.5 Gy × 2 F) vs40′ (7.5 Gy × 2F), *P*= 0.035; 20′ (3 Gy × 5 F) vs40′ (3 Gy × 5 F); *P*= 0.054; 20′ (1.67 Gy × 9 F) vs40′ (1.67 Gy × 9 F), *P*= 0.028; Table [6](#RRS093TB6){ref-type="table"}\]. Fig. 3.Effects of fractionated irradiation on A549 cell survival. Cells received fractionated irradiation of 2 Gy, 2 Gy × 2, 2 Gy × 3, and 2 Gy × 4, given with one fraction per day simulating clinical dose-time-fractionation pattern. Each fraction dose was given in two equal sub-fractions, with a total fraction delivery time of 2min, 20 min, and 40 min per fraction. Fig. 4.Radiation decreased A549-derived tumor volumes. Growth of A549-derived tumors in nude mice was monitored as described in the Materials and Methods section. Tumor volume was decreased after a single dose of 15 Gy, or 15 Gy given as 2, 5, or 9 subfractions for 20 min or 40 min. Bars represent SD for eight mice. Table 4.Tumor growth time (TGT) to reach four times the initial volumeGroupTGT (days)MeanSE15 Gy as a single dose9.21.820′ (7.5 Gy × 2 F)6.73.920′ (3 Gy × 5 F)7.02.220′ (1.67 Gy × 9 F)8.23.940′ (7.5 Gy × 2 F)3.92.640′ (3 Gy × 5 F)4.42.440′ (1.67 Gy × 9 F)5.22.5 Table 5.Results of t-tests for TGT for the 20 min or 40 min groups with different subfractionsGroup vs Group*P*20′ (7.5 Gy × 2 F) vs 20′ (3 Gy × 5 F)0.8520′ (7.5 Gy × 2 F) vs 20′ (1.67 Gy × 9 F)0.2720′ (3 Gy × 5 F) vs 20′ (1.67 Gy × 9 F)0.3540′ (7.5 Gy × 2 F) vs 40′ (3 Gy × 5 F)0.7140′ (7.5 Gy × 2 F) vs 40′ (1.67 Gy × 9 F)0.3140′ (3 Gy × 5 F) vs 40′ (1.67 Gy × 9 F)0.51 Table 6.Results of t-tests for TGT for the 20 min and 40 min groups with the same subfractionsGroup vs Group*P*20′ (7.5 Gy × 2 F) vs 40′ (7.5 Gy × 2 F)0.03520′ (3 Gy × 5 F) vs 40′ (3 Gy × 5 F)0.05420′ (1.67 Gy × 9 F) vs 40′ (1.67 Gy × 9 F)0.028

DISCUSSION {#s4}
==========

The LQ model was used to examine the relationship between prolonged fraction delivery time and the radiobiological effects. While much work has been done to evaluate the effects of radiation on tumor cells, a few radiobiological issues remain unresolved regarding the evaluation of radiation doses employed in the treatment modalities. Here, we investigated the association between delivery time and the radiobiological effects using both *in vitro*and *in vivo*models.

After radiation of cultured mammalian cells, cell survival increased when intervals were used between two radiation doses \[[@RRS093C7]--[@RRS093C9]\]; the phenomenon is known as SLDR. Wang *et al*. \[[@RRS093C12]\] calculated the influence of prolonged fraction delivery time using the generalized LQ model, and cautioned that the total time to deliver a single fraction may have a significant impact on IMRT treatment outcome for tumors with a low α/β ratio and a short repair half-time, such as prostate cancer. Mu *et al*. \[[@RRS093C13]\] showed that several radiobiological models underestimated the reduced efficiency of 10 and 20 min prolonged delivery of 2 Gy fractions to V79 Chinese hamster lung cells, while prolonging the fraction time spares tissues with rapid DNA repair. Zheng *et al*. \[[@RRS093C14]\] found that prolonged fraction delivery time modeling IMRT significantly decreased cell killing in HepG2 human hepatocellular carcinoma cells, but not in Hep3b cells. The authors proposed that SLDR was the predominant factor that decreased cell killing. In our *in vitro*study, cell survival increased when the interfraction interval was longer. These observations are consistent with a previous report that showed that cell survival increased in mouse EMT6 and SCCVII cells receiving fractionated radiation \[[@RRS093C15]\]. Shibamoto *et al*. \[[@RRS093C16]\] reviewed the current literature and concluded that two-fraction irradiation would yield the greatest effect among the fractionated radiation groups.

A previous *in vitro*study showed that the biological effects of radiation significantly decreased in EMT6 and SCCVII cells when doses of 2 and 8 Gy were delivered in 2, 5 or 10 fractions and the interfraction intervals were 2 min or longer \[[@RRS093C17]\]. The results of the *in vivo*study, however, were in striking contrast with those of the *in vitro*studies. In the 2-fraction experiments, the increase in cell survival with elongation of intervals was much less than that observed in the *in vitro*study \[[@RRS093C18]\]. In both of the 5- and 10-fraction experiments, no significant increase in cell survival resulting from fractionation was observed. Moreover, cell survival decreased at various time points when radiation exposure was interrupted. Therefore, SLDR *in vivo*might be counterbalanced by other phenomena, such as reoxygenation, that sensitize tumor cells to subsequent irradiation \[[@RRS093C18]\]. Further studies have shown that reoxygenation occurring within 5 to 15 min compensated for SLDR in SCCVII tumors. When reoxygenation was limited, the radiation effect due to SLDR decreased, indicating that reoxygenation of about one-third of hypoxic tumor cells would counter-balance SLDR *in vivo*\[[@RRS093C19]\]. In contrast, in the present study, the prolonged fraction delivery time decreased the radiobiological effects *in vivo*. This difference may be due to the irradiation conditions for tumor-bearing mice. Sugie *et al*. \[[@RRS093C18]\] irradiated mice without anesthesia or physical restraint, while we irradiated mice after immobilizing them in jigs. This change in irradiation conditions can produce dramatic effects in tumor oxygenation \[[@RRS093C20]\].

Collectively, our *in vitro*and *in vivo*results showed that prolonged fraction delivery time substantially undermined the radiobiological effects. Therefore, we strongly recommend keeping the delivery time as short as possible, to prevent slow or insufficient reoxygenation of the tumor. However, some concerns must still be addressed. First, the effect of different delivery times in real clinical usage may differ because of the heterogeneous nature of damage repair in different cell lines. Second, the underlying mechanisms involved in the decreased biological effects with prolonged radiation treatment times are yet to be determined. Third, the effect of instantaneous dose rate, beam time and size, and the number of segments could be much more complicated than what our data provided via simplified estimation on human tumor cell and it needs further investigation.
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[^1]: SF~2READ~= surviving fractions of 2 Gy (read), SF~2ESTimate~= surviving fractions of 2 Gy (estimated).
